{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T01:35:47Z","timestamp":1715996147581},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,5,19]],"date-time":"2010-05-19T00:00:00Z","timestamp":1274227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s11899-010-0055-9","type":"journal-article","created":{"date-parts":[[2010,5,18]],"date-time":"2010-05-18T03:53:32Z","timestamp":1274154812000},"page":"163-168","source":"Crossref","is-referenced-by-count":13,"title":["Rare Pediatric Non-Hodgkin Lymphoma"],"prefix":"10.1007","volume":"5","author":[{"given":"Bhuvana A.","family":"Setty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda M.","family":"Termuhlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,19]]},"reference":[{"key":"55_CR1","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJM199605093341906","volume":"334","author":"JT Sandlund","year":"1996","unstructured":"Sandlund JT, Downing JR, Crist WM: Non-Hodgkin\u2019s lymphoma in childhood. N Engl J Med 1996, 334:1238\u20131248.","journal-title":"N Engl J Med"},{"key":"55_CR2","unstructured":"WHO Classification of Tumors of the Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2008."},{"key":"55_CR3","doi-asserted-by":"crossref","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification Project. Blood 1997, 89:3909\u20133918.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"55_CR4","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1200\/JCO.2001.19.6.1855","volume":"19","author":"K Besien van","year":"2001","unstructured":"van Besien K, Kelta M, Bahaguna P. Primary mediastinal B-cell lymphoma: a review of pathology and management. J Clin Oncol 2001, 19:1855\u20131864.","journal-title":"J Clin Oncol"},{"key":"55_CR5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1470-2045(02)00714-3","volume":"3","author":"TF Barth","year":"2002","unstructured":"Barth TF, Leithauser F, Joos S, et al.: Mediastinal (thymic) large B-cell lymphoma: Where do we stand? Lancet Oncol 2002, 3:229\u2013234.","journal-title":"Lancet Oncol"},{"key":"55_CR6","doi-asserted-by":"crossref","unstructured":"Johnson PW, Davies AJ: Primary mediastinal B-cell lymphoma. Hematology Am Soc Hematol Educ Program 2008:349\u2013358.","DOI":"10.1182\/asheducation-2008.1.349"},{"key":"55_CR7","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, et al.: A revised European\u2013American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994, 84:1361\u20131392.","journal-title":"Blood"},{"key":"55_CR8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood-2005-11-4742","volume":"108","author":"RA Roberts","year":"2006","unstructured":"Roberts RA, Wright G, Rosenwald AR, et al.: Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival. Blood 2006, 108:311\u2013318.","journal-title":"Blood"},{"key":"55_CR9","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","volume":"102","author":"KJ Savage","year":"2003","unstructured":"Savage KJ, Monti S, Kutok JL, et al.: The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003, 102:3871\u20133879.","journal-title":"Blood"},{"key":"55_CR10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/annonc\/mdj030","volume":"17","author":"KJ Savage","year":"2006","unstructured":"Savage KJ, Al-Rajhi N, Voss N, et al.: Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. Ann Oncol 2006, 17:123\u2013130.","journal-title":"Ann Oncol"},{"key":"55_CR11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/pbc.21821","volume":"52","author":"D Attias","year":"2009","unstructured":"Attias D, Hodgson D, Weitzman S: Primary mediastinal B-cell lymphoma in the pediatric patient: Can a rational approach to therapy be based on adult studies? Pediatr Blood Cancer 2009, 52:566\u2013570.","journal-title":"Pediatr Blood Cancer"},{"key":"55_CR12","first-page":"361","volume":"43","author":"GM Cairo","year":"2004","unstructured":"Gerrard M Cairo MS, Weston C, et al.: Primary mediastinal large B-cell lymphoma: results of the FABLMB 96 study [abstract 0.134]. Pediatr Blood Cancer 2004, 43:361\u2013362.","journal-title":"Pediatr Blood Cancer"},{"key":"55_CR13","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","volume":"109","author":"C Patte","year":"2007","unstructured":"Patte C, Auperin A, Gerrard M, et al.: Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: It is possible to reduce treatment for the early responding patients. Blood 2007, 109:2773\u20132780.","journal-title":"Blood"},{"key":"55_CR14","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1200\/JCO.2003.08.151","volume":"21","author":"K Seidemann","year":"2003","unstructured":"Seidemann K, Tiemann M, Lauterbach I, et al.: Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Munster Group. J Clin Oncol 2003, 21:1782\u20131789.","journal-title":"J Clin Oncol"},{"key":"55_CR15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cancergencyto.2006.04.015","volume":"170","author":"E Stejskalova","year":"2006","unstructured":"Stejskalova E, Jarosova M, Kabickova E, et al.: Primary mediastinal (thymic) large B-cell lymphoma with a der(14)t(8, 14)(q24, q32) and a translocation of MYC to the derivative chromosome 14 with a deleted IgH locus. Cancer Genet Cytogenet 2006, 170:158\u2013162.","journal-title":"Cancer Genet Cytogenet"},{"key":"55_CR16","first-page":"1258","volume":"87","author":"PL Zinzani","year":"2002","unstructured":"Zinzani PL, Martelli M, Bertini M, et al.: Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. Haematologica 2002, 87:1258\u20131264.","journal-title":"Haematologica"},{"key":"55_CR17","doi-asserted-by":"crossref","unstructured":"Dunleavy K, Pittaluga S, Janik J, et al.: Primary mediastinal large B-cell lymphoma (PMBL) outcome may be significantly improved by the addition of rituximab to dose-adjusted (DA)-EPOCH and obviates the need for radiation: results from a prospective study of 44 patients [abstract]. Blood (ASH Annual Meeting Abstracts) 2006, 108(11):Abstract 209.","DOI":"10.1182\/blood.V108.11.209.209"},{"key":"55_CR18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2141.2008.06988.x","volume":"142","author":"A Reiter","year":"2008","unstructured":"Reiter A, Klapper W: Recent advances in the understanding and management of diffuse large B-cell lymphoma in children. Br J Haematol 2008, 142:329\u2013347.","journal-title":"Br J Haematol"},{"key":"55_CR19","doi-asserted-by":"crossref","unstructured":"\u2022 Oschlies I, Salaverria I, Mahn F, et al.: Pediatric follicular lymphoma\u2014a clinico-pathological study of a population-based series of patients treated within the Non-Hodgkin\u2019s Lymphoma\u2013Berlin-Frankfurt-Munster (NHL-BFM) multicenter trials. Haematologica 2010, 95:253\u2013259. This report on a large series of pediatric follicular lymphoma patients treated in the BFM-NHL trials in Germany includes immune characterization, molecular studies, and outcome. There were 25 patients with a median age of 11\u00a0years (range, 1\u201317\u00a0years) diagnosed with follicular lymphoma, of whom 81% were CD10+, 94% were Bcl6+, and all were negative for the fusion between IGH and the Bcl2 loci. The 5-year EFS was 96%\u2009\u00b1\u20094%.","DOI":"10.3324\/haematol.2009.013177"},{"key":"55_CR20","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.V99.6.1959","volume":"99","author":"RB Lorsbach","year":"2002","unstructured":"Lorsbach RB, Shay-Seymore D, Moore J, et al.: Clinicopathologic analysis of follicular lymphoma occurring in children. Blood 2002, 99:1959\u20131964.","journal-title":"Blood"},{"key":"55_CR21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5858\/133.1.142","volume":"133","author":"R Agrawal","year":"2009","unstructured":"Agrawal R, Wang J: Pediatric follicular lymphoma: a rare clinicopathologic entity. Arch Pathol Lab Med 2009, 133:142\u2013146.","journal-title":"Arch Pathol Lab Med"},{"issue":"Suppl","key":"55_CR22","first-page":"S98","volume":"122","author":"SH Swerdlow","year":"2004","unstructured":"Swerdlow SH: Pediatric follicular lymphomas, marginal zone lymphomas, and marginal zone hyperplasia. Am J Clin Pathol 2004, 122(Suppl):S98\u2013S109.","journal-title":"Am J Clin Pathol"},{"key":"55_CR23","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/1097-0142(19811115)48:10<2223::AID-CNCR2820481018>3.0.CO;2-T","volume":"48","author":"CD Winberg","year":"1981","unstructured":"Winberg CD, Nathwani BN, Bearman RM, et al.: Follicular (nodular) lymphoma during the first two decades of life: a clinicopathologic study of 12 patients. Cancer 1981, 48:2223\u20132235.","journal-title":"Cancer"},{"key":"55_CR24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood.V86.1.28.bloodjournal86128","volume":"86","author":"T Onizuka","year":"1995","unstructured":"Onizuka T, Moriyama M, Yamochi T, et al.: BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood 1995, 86:28\u201337.","journal-title":"Blood"},{"key":"55_CR25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1365-2141.1998.00941.x","volume":"103","author":"A Atra","year":"1998","unstructured":"Atra A, Meller ST, Stevens RS, et al.: Conservative management of follicular non-Hodgkin\u2019s lymphoma in childhood. Br J Haematol 1998, 103:220\u2013223.","journal-title":"Br J Haematol"},{"key":"55_CR26","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood-2005-10-4213","volume":"107","author":"I Oschlies","year":"2006","unstructured":"Oschlies I, Klapper W, Zimmermann M, et al.: Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial. Blood 2006, 107:4047\u20134052.","journal-title":"Blood"},{"key":"55_CR27","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"R Willemze","year":"2005","unstructured":"Willemze R, Jaffe ES, Burg G, et al.: WHO-EORTC classification for cutaneous lymphomas. Blood 2005, 105:3768\u20133785.","journal-title":"Blood"},{"key":"55_CR28","doi-asserted-by":"crossref","unstructured":"\u2022 Senff NJ, Noordijk EM, Kim YH, et al.: European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Blood 2008, 112:1600\u20131609. This is an excellent consensus review of cutaneous B-cell lymphomas.","DOI":"10.1182\/blood-2008-04-152850"},{"key":"55_CR29","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/10428190500399698","volume":"47","author":"A Cozzio","year":"2006","unstructured":"Cozzio A, Kempf W, Schmid-Meyer R, et al.: Intra-lesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma. Leuk Lymphoma 2006, 47:865\u2013869.","journal-title":"Leuk Lymphoma"},{"key":"55_CR30","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1365-2133.2006.07523.x","volume":"155","author":"K Kerl","year":"2006","unstructured":"Kerl K, Prins C, Saurat JH, French LE: Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases. Br J Dermatol 2006, 155:1197\u20131200.","journal-title":"Br J Dermatol"},{"key":"55_CR31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ajh.20019","volume":"75","author":"A Sah","year":"2004","unstructured":"Sah A, Barrans SL, Parapia LA, et al.: Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients. Am J Hematol 2004, 75:195\u2013199.","journal-title":"Am J Hematol"},{"key":"55_CR32","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/archderm.143.12.1520","volume":"143","author":"NJ Senff","year":"2007","unstructured":"Senff NJ, Hoefnagel JJ, Neelis KJ et al.: Results of radiotherapy in 153 primary cutaneous B-cell lymphomas classified according to the WHO-EORTC classification. Arch Dermatol 2007, 143:1520\u20131526.","journal-title":"Arch Dermatol"},{"key":"55_CR33","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1182\/blood.V95.12.3922","volume":"95","author":"L Cerroni","year":"2000","unstructured":"Cerroni L, Arzberger E, Putz B, et al.: Primary cutaneous follicle center cell lymphoma with follicular growth pattern. Blood 2000, 95:3922\u20133928.","journal-title":"Blood"},{"key":"55_CR34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00000478-199205000-00004","volume":"16","author":"C Schmid","year":"1992","unstructured":"Schmid C, Kirkham N, Diss T, Isaacson PG: Splenic marginal zone cell lymphoma. Am J Surg Pathol 1992, 16:455\u2013466.","journal-title":"Am J Surg Pathol"},{"key":"55_CR35","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3816\/CLM.2004.n.005","volume":"4","author":"L Arcaini","year":"2004","unstructured":"Arcaini L, Orlandi E, Scotti M, et al.: Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma. Clin Lymphoma 2004, 4:250\u2013252.","journal-title":"Clin Lymphoma"},{"key":"55_CR36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2004-05-1711","volume":"105","author":"D Saadoun","year":"2005","unstructured":"Saadoun D, Suarez F, Lefrere F, et al.: Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood 2005, 105:74\u201376.","journal-title":"Blood"},{"key":"55_CR37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1600-0609.2009.01301.x","volume":"83","author":"L Arcaini","year":"2009","unstructured":"Arcaini L, Lucioni M, Boveri E, Paulli M: Nodal marginal zone lymphoma: current knowledge and future directions of an heterogeneous disease. Eur J Haematol 2009, 83:165\u2013174.","journal-title":"Eur J Haematol"},{"key":"55_CR38","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1200\/JCO.2005.02.050","volume":"23","author":"OA O\u2019Connor","year":"2005","unstructured":"O\u2019Connor OA, Wright J, Moskowitz C, et al.: Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin\u2019s lymphoma and mantle cell lymphoma. J Clin Oncol 2005, 23:676\u2013684.","journal-title":"J Clin Oncol"},{"key":"55_CR39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/10428190310001593157","volume":"45","author":"JR Brown","year":"2004","unstructured":"Brown JR, Gaudet G, Friedberg JW, et al.: Autologous bone marrow transplantation for marginal zone non-Hodgkin\u2019s lymphoma. Leuk Lymphoma 2004, 45:315\u2013320.","journal-title":"Leuk Lymphoma"},{"key":"55_CR40","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/1097-0142(19840601)53:11<2515::AID-CNCR2820531125>3.0.CO;2-C","volume":"53","author":"P Isaacson","year":"1984","unstructured":"Isaacson P, Wright DH: Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 1984, 53:2515\u20132524.","journal-title":"Cancer"},{"key":"55_CR41","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0140-6736(93)91408-E","volume":"342","author":"T Hussell","year":"1993","unstructured":"Hussell T, Isaacson PG, Crabtree JE, Spencer J: The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993, 342:571\u2013574.","journal-title":"Lancet"},{"key":"55_CR42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10024-003-3025-6","volume":"7","author":"JQ Mo","year":"2004","unstructured":"Mo JQ, Dimashkieh H, Mallery SR, et al.: MALT lymphoma in children: case report and review of the literature. Pediatr Dev Pathol 2004, 7:407\u2013413.","journal-title":"Pediatr Dev Pathol"},{"key":"55_CR43","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/pbc.20575","volume":"47","author":"A Claviez","year":"2006","unstructured":"Claviez A, Meyer U, Dominick C, et al.: MALT lymphoma in children: a report from the NHL-BFM Study Group. Pediatr Blood Cancer 2006, 47:210\u2013214.","journal-title":"Pediatr Blood Cancer"},{"key":"55_CR44","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.tripleo.2008.10.013","volume":"107","author":"M Ryu","year":"2009","unstructured":"Ryu M, Han S, Che Z, et al.: Pediatric mucosa-associated lymphoid tissue (MALT) lymphoma of lip: a case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 107:393\u2013397.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"Suppl 2","key":"55_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0560.2006.00506.x","volume":"33","author":"N Sroa","year":"2006","unstructured":"Sroa N, Magro CM: Pediatric primary cutaneous marginal zone lymphoma: in association with chronic antihistamine use. J Cutan Pathol 2006, 33(Suppl 2):1\u20135.","journal-title":"J Cutan Pathol"},{"key":"55_CR46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/pbc.22384","volume":"54","author":"R Kobayashi","year":"2010","unstructured":"Kobayashi R, Yamato K, Tanaka F, et al.: Retrospective analysis of non-anaplastic peripheral T-cell lymphoma in pediatric patients in Japan. Pediatr Blood Cancer 2010, 54:212\u2013215.","journal-title":"Pediatr Blood Cancer"},{"key":"55_CR47","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","volume":"13","author":"T Rudiger","year":"2002","unstructured":"Rudiger T, Weisenburger DD, Anderson JR, et al.: Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin\u2019s Lymphoma Classification Project. Ann Oncol 2002, 13:140\u2013149.","journal-title":"Ann Oncol"},{"key":"55_CR48","first-page":"314","volume":"12","author":"BA Agnarsson","year":"1995","unstructured":"Agnarsson BA, Kadin ME: Peripheral T-cell lymphomas in children. Semin Diagn Pathol 1995, 12:314\u2013324.","journal-title":"Semin Diagn Pathol"},{"key":"55_CR49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pbc.21543","volume":"51","author":"RE Hutchison","year":"2008","unstructured":"Hutchison RE, Laver JH, Chang M, et al.: Non-anaplastic peripheral T-cell lymphoma in childhood and adolescence: a Children\u2019s Oncology Group study. Pediatr Blood Cancer 2008, 51:29\u201333.","journal-title":"Pediatr Blood Cancer"},{"key":"55_CR50","doi-asserted-by":"crossref","unstructured":"\u2022 Windsor R, Stiller C, Webb D: Peripheral T-cell lymphoma in childhood: population-based experience in the United Kingdom over 20\u00a0years. Pediatr Blood Cancer 2008, 50:784\u2013787. This is a large series of pediatric peripheral T-cell lymphomas from a population-based registry, reporting on 25 patients with a median age of 7\u00a0years. Peripheral T-cell lymphoma not otherwise specified constituted 68% of the pediatric peripheral T-cell cases. Overall survival was 66% for localized disease and 54% for advanced disease.","DOI":"10.1002\/pbc.21293"},{"key":"55_CR51","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/1042819021000030054","volume":"44","author":"ER Arrowsmith","year":"2003","unstructured":"Arrowsmith ER, Macon WR, Kinney MC, et al.: Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification. Leuk Lymphoma 2003, 44:241\u2013249.","journal-title":"Leuk Lymphoma"},{"key":"55_CR52","first-page":"1109","volume":"85","author":"M Massimino","year":"2000","unstructured":"Massimino M, Perotti D, Spreafico F et al.: Non-ALC peripheral T-cell lymphomas in children: report on two cases and review of the literature. Haematologica 2000, 85:1109\u20131111.","journal-title":"Haematologica"},{"key":"55_CR53","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/annonc\/mdh392","volume":"15","author":"KJ Savage","year":"2004","unstructured":"Savage KJ, Chhanabhai M, Gascoyne RD, Connors JM: Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol 2004, 15:1467\u20131475.","journal-title":"Ann Oncol"},{"key":"55_CR54","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2005-03-1306","volume":"107","author":"MA Rizvi","year":"2006","unstructured":"Rizvi MA, Evens AM, Tallman MS, et al.: T-cell non-Hodgkin lymphoma. Blood 2006, 107:1255\u20131264.","journal-title":"Blood"},{"key":"55_CR55","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","volume":"111","author":"KJ Savage","year":"2008","unstructured":"Savage KJ, Harris NL, Vose JM, et al.: ALK\u2212 anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood 2008, 111:5496\u20135504.","journal-title":"Blood"},{"key":"55_CR56","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10024-004-8087-6","volume":"8","author":"S Kumar","year":"2005","unstructured":"Kumar S, Pittaluga S, Raffeld M, et al.: Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature. Pediatr Dev Pathol 2005, 8:52\u201360.","journal-title":"Pediatr Dev Pathol"},{"key":"55_CR57","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1346-8138.2009.00665.x","volume":"36","author":"ST Kim","year":"2009","unstructured":"Kim ST, Sim HJ, Jeon YS, et al.: Clinicopathological features and T-cell receptor gene rearrangement findings of mycosis fungoides in patients younger than age 20\u00a0years. J Dermatol 2009, 36:392\u2013402.","journal-title":"J Dermatol"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-010-0055-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-010-0055-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-010-0055-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T23:02:40Z","timestamp":1635375760000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-010-0055-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,19]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["55"],"URL":"https:\/\/doi.org\/10.1007\/s11899-010-0055-9","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,19]]}}}